| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |